0

Journal Articles

in Diabetes Mellitus
 101-120 of 1325 Articles
JAMA Surgery | 
Original Article |  August 01, 2012
Obesity, Type 2 Diabetes Mellitus, and Other Comorbidities:  A Prospective Cohort Study of Laparoscopic Sleeve Gastrectomy vs Medical Treatment
Frida Leonetti, MD, PhD; Danila Capoccia, MD; Federica Coccia, MD; et al.
Arch Surg. 2012;147(8):694-700. doi:10.1001/archsurg.2012.222.
JAMA Surgery | 
Invited Critique |  August 01, 2012
Bariatric Surgery as a Highly Effective Intervention for Diabetes: News Flash or Preaching to the Choir?:  Comments on “Obesity, Type 2 Diabetes Mellitus, and Other Comorbidities”
Jon C. Gould, MD
Arch Surg. 2012;147(8):700. doi:10.1001/archsurg.2012.227.
JAMA Internal Medicine | 
Correction |  July 23, 2012
Error in Text in: Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis
Arch Intern Med. 2012;172(14):1095. doi:10.1001/archinternmed.2012.3617.
JAMA Internal Medicine | 
Original Investigation |  July 09, 2012
Association Between Thiazolidinedione Treatment and Risk of Macular Edema Among Patients With Type 2 Diabetes
Iskandar Idris, MD, FRCP, FRCP(Edin); Graham Warren, PhD; Richard Donnelly, MD, PhD
Arch Intern Med. 2012;172(13):1005-1011. doi:10.1001/archinternmed.2012.1938.
JAMA Internal Medicine | 
Evidence to Practice |  July 09, 2012
Comparative Effectiveness of Anti–Growth Factor Therapies for Diabetic Macular Edema:  Summary of Primary Findings and Conclusions
Patrick G. O’Malley, MD, MPH
Arch Intern Med. 2012;172(13):1014-1015. doi:10.1001/archinternmed.2012.2335.
JAMA Internal Medicine | 
Invited Commentary |  July 09, 2012
Thiazolidinediones and Macular Edema:  Comment on “Association Between Thiazolidinedione Treatment and Risk of Macular Edema Among Patients With Type 2 Diabetes”
Sonal Singh, MD, MPH; Jodi B. Segal, MD, MPH
Arch Intern Med. 2012;172(13):1011-1013. doi:10.1001/archinternmed.2012.2461.
JAMA | 
Medical News and Perspectives |  July 04, 2012
Prompt Response, Multidisciplinary Care Key to Reducing Diabetic Foot Amputation
Bridget M. Kuehn
JAMA. 2012;308(1):19-20. doi:10.1001/jama.2012.6778.
JAMA Pediatrics | 
Article |  July 01, 2012
Effect of Cholecalciferol as Adjunctive Therapy With Insulin on Protective Immunologic Profile and Decline of Residual β-Cell Function in New-Onset Type 1 Diabetes Mellitus
Mônica A. L. Gabbay, MD, PhD; Maria N. Sato, MD, PhD; Claudia Finazzo, MS(Biomed); et al.
Arch Pediatr Adolesc Med. 2012;166(7):601-607. doi:10.1001/archpediatrics.2012.164.
JAMA Surgery | 
Invited Critique |  July 01, 2012
Risky Business?:  Comment on “Risk Factors for Anastomotic Leak and Mortality in Diabetic Patients Undergoing Colectomy”
Jeffrey B. Matthews, MD
Arch Surg. 2012;147(7):605-606. doi:10.1001/archsurg.2012.288.
JAMA Surgery | 
Original Article |  July 01, 2012
Risk Factors for Anastomotic Leak and Mortality in Diabetic Patients Undergoing Colectomy:  Analysis From a Statewide Surgical Quality Collaborative
Matthew A. Ziegler, MD; James A. Catto, MD; Thomas W. Riggs, MD, PhD; et al.
Arch Surg. 2012;147(7):600-605. doi:10.1001/archsurg.2012.77.
INCLUDES: CME
JAMA | 
Medical News and Perspectives |  June 27, 2012
Diabetes Drug Is Linked With Bladder Cancer Risk
Rebecca Voelker
JAMA. 2012;307(24):2577. doi:10.1001/jama.2012.7131.
JAMA Internal Medicine | 
Invited Commentary |  June 25, 2012
How Do Guidelines Impact Measures of Performance? Can They Keep Up?:  Comment on “Monitoring Performance for Blood Pressure Management Among Patients With Diabetes Mellitus”
Eileen Handberg, PhD
Arch Intern Med. 2012;172(12):945-946. doi:10.1001/archinternmed.2012.2261.
JAMA | 
Viewpoint |  June 20, 2012
A Lifecycle Approach to the Evaluation of FDA Approval Methods and Regulatory Actions:  Opportunities Provided by a New IOM Report
Bruce M. Psaty, MD, PhD; Eric M. Meslin, PhD; Alasdair Breckenridge, MD, FRCP
JAMA. 2012;307(23):2491-2492. doi:10.1001/jama.2012.5545.
JAMA | 
Medical News and Perspectives |  June 20, 2012
IOM Urges FDA to Be More Aggressive in Monitoring Safety of Approved Drugs
Bridget M. Kuehn
JAMA. 2012;307(23):2475-2476. doi:10.1001/jama.2012.5993.
JAMA Internal Medicine | 
Editor's Correspondence |  June 11, 2012
Statins and the Risk of Diabetes: The Debate
Niki Katsiki, MSc, PhD, MD, FRSPH; Maciej Banach, MD, PhD, FAHA, FESC, FASA, FRSPH
Arch Intern Med. 2012;172(11):895-896. doi:10.1001/archinternmed.2012.1240.
JAMA Internal Medicine | 
Editor's Correspondence |  June 11, 2012
Statin Use and Risk of Diabetes
Harold Zeliger, PhD
Arch Intern Med. 2012;172(11):896-897. doi:10.1001/archinternmed.2012.1243.
JAMA Internal Medicine | 
Editor's Correspondence |  June 11, 2012
Statin Use and Risk of Diabetes—Reply
Annie L. Culver, BPharm; Ira S. Ockene, MD; Yunsheng Ma, MD, PhD
Arch Intern Med. 2012;172(11):896-897. doi:10.1001/archinternmed.2012.1613.
JAMA | 
Editorial |  June 06, 2012
Hemorrhagic Complications Associated With Aspirin:  An Underestimated Hazard in Clinical Practice?
Jolanta M. Siller-Matula, MD, PhD
JAMA. 2012;307(21):2318-2320. doi:10.1001/jama.2012.6152.
JAMA | 
Lab Reports |  June 06, 2012
Drug Linked With Diabetes
Tracy Hampton, PhD
JAMA. 2012;307(21):2247. doi:10.1001/jama.2012.5729.
JAMA | 
Medical News and Perspectives |  June 06, 2012
Guidelines Ease Up on Glycemic Control for Some Patients With Type 2 Diabetes
Mike Mitka
JAMA. 2012;307(21):2243-2244. doi:10.1001/jama.2012.5242.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Editorial  |  June 19, 2013
The Evolution of Type 1 Diabetes
Jay S. Skyler, MD; Jay M. Sosenko, MD
JAMA
Original Contribution  |  June 19, 2013
Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children
Anette G. Ziegler, MD; Marian Rewers, MD, PhD; Olli Simell, MD, PhD; et al.
JAMA Internal Medicine
Original Investigation  |  June 17, 2013
Changes in Red Meat Consumption and Subsequent Risk of Type 2 Diabetes Mellitus:  Three Cohorts of US Men and Women
An Pan, PhD; Qi Sun, MD, ScD; Adam M. Bernstein, MD, ScD; et al.
JAMA Internal Medicine
Invited Commentary  |  June 17, 2013
Oxygen-Carrying Proteins in Meat and Risk of Diabetes Mellitus :  Comment on “Changes in Red Meat Consumption and Subsequent Risk of Type 2 Diabetes Mellitus: Three Cohorts of US Men and Women”
William J. Evans, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems